Status:

COMPLETED

A Study to Compare Two Ways of Completing Pain and Sleep Questions and to Evaluate a New Daily Questionaire for Assessing Fatigue in Fibromyalgia Patients

Lead Sponsor:

Pfizer

Conditions:

Fibromyalgia

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

The study has two goals. The first goal of the study is to compare two methods of administering questions about pain and sleep interference. The two methods being compared are a telephone based system...

Eligibility Criteria

Inclusion

  • Fibromyalgia using ACR diagnosis

Exclusion

  • Other confounding disease including other inflammatory disease, pain and depression

Key Trial Info

Start Date :

January 1 2009

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

March 1 2009

Estimated Enrollment :

185 Patients enrolled

Trial Details

Trial ID

NCT00819624

Start Date

January 1 2009

End Date

March 1 2009

Last Update

February 15 2010

Active Locations (15)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 4 (15 locations)

1

Pfizer Investigational Site

Roseville, California, United States, 95661

2

Pfizer Investigational Site

Baton Rouge, Louisiana, United States, 70809

3

Pfizer Investigational Site

North Dartmouth, Massachusetts, United States, 02747

4

Pfizer Investigational Site

Jefferson City, Missouri, United States, 65109